文献速递免疫规划卫生政策与健康促进

瑞典斯德哥尔摩公开资助蜱传脑炎疫苗接种的成本效果分析

Estimating costs and health outcomes of publicly funded tick-born encephalitis vaccination: A cost-effectiveness analysis.
PubMed 文献 · Vaccine · 2018-10-30

该研究用Markov模型评估斯德哥尔摩3岁、40岁和50岁队列中,由医保全额资助的结构化TBE疫苗接种策略与自费策略相比的终身成本与健康产出。结构化接种增加QALY且成本更高,3岁、40岁、50岁队列的ICER分别为27 761、99 527和160 827 SEK/QALY。作者认为尤其在3岁儿童中,该免费接种项目的每QALY成本低于瑞典通常可接受的成本效果阈值。

要点

  • 结构化免费TBE接种较自费策略增加QALY但成本更高。
  • 3岁、40岁、50岁队列ICER分别为27 761、99 527、160 827 SEK/QALY。
  • 敏感性分析显示结果在不同参数变化下稳健。

核心结论

  • 在斯德哥尔摩地区,免费TBE疫苗接种项目每获得一个QALY的成本,尤其对3岁儿童,低于瑞典通常可接受的成本效果阈值。

研究设计与样本

  • 研究采用Markov模型,从第三方医疗支付方视角、终身时间 horizon 估算成本与QALY。
  • 设置3岁、40岁和50岁三个队列,比较自费策略(队列中53%自费接种)与结构化接种项目(全队列由公共资助医疗系统覆盖接种)。

主要发现

  • 结构化接种项目较自费策略带来QALY增益且成本增加。
  • 3岁、40岁和50岁队列的ICER分别为27 761、99 527和160 827 SEK/QALY。
  • 敏感性分析显示结果在不同参数变化下稳健。

关键数值与推荐

  • 自费策略中53%的队列成员自费接种疫苗。
  • 3岁、40岁和50岁队列的ICER分别为27 761、99 527和160 827 SEK/QALY。

临床怎么用

  • 可为斯德哥尔摩地区将TBE疫苗纳入公共资助接种项目提供成本效果依据。
  • 决策时可优先考虑对3岁儿童实施免费TBE疫苗接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The number of notified cases of Tick-Borne Encephalitis (TBE) in Sweden has been increasing the past years despite the increased use of TBE-vaccine not subsidized by the healthcare system. Stockholm County is a high endemic area and an earlier study has shown that low-income households have lower vaccination coverage even when they are at high risk. This paper aims to determine the cost-effectiveness of a publicly funded TBE vaccination program in Stockholm. METHODS: In three different cohorts with individuals aged 3, 40 or 50 years, long-term costs and health outcomes of an out-of-pocket strategy (53% of the cohort is vaccinated on their own expenses) and a structured vaccination program (full cohort is vaccinated covered by the publicly funded health care system), were estimated using a Markov model. The Markov model predicts the costs and effects in term of Quality-adjusted Life Years (QALYs) over a lifetime horizon using a third-party healthcare payer perspective. The primary results are presented as an incremental cost effectiveness ratio (ICER) indicating the additional cost required to achieve one additional QALY with the structured vaccination program. RESULTS: The results show that the structured vaccination program is associated with a gain in QALYs and increased costs compared with an out-of-pocket strategy. The calculated ICERs were 27 761, 99 527 and 160 827 SEK/QALY in cohorts of age 3, 40 and 50, respectively. The sensitivity analyses showed that the results are robust when varying different parameters. CONCLUSION: Given the setting of Stockholm county, this analysis shows a cost per QALY of a free vaccinations program, especially for children of 3 years old, below generally acceptable cost-effectiveness thresholds in Sweden.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Shedrawy J, Henriksson M, Hergens MP, et al. Estimating costs and health outcomes of publicly funded tick-born encephalitis vaccination: A cost-effectiveness analysis. Vaccine. 2018. PMID: 30385058. doi:10.1016/j.vaccine.2018.10.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。